GAS5 and osteosarcoma: In addition, GAS5 also enhances the sensitivity of osteosarcoma cells to Cisplatin through the GAS5/miR-26b-5p/TP53INP1 axis, which may be a potential indicator for the treatment of osteosarcoma (92).